Evidence map›Paper›PMID 36685928›Full record

ArticleFrontiers in genetics2022

Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer.

Yangyang Guo, Qiaoqiao Chen, Yingjue Zhang, Xu Cheng, Kenan Cen, Ying Dai, Yifeng Mai, Kai Hong

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Yangyang GuoDepartment of Thyroid and Breast Surgery, Ningbo First Hospital, Ningbo, China.
Qiaoqiao ChenReproductive Medicine Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Yingjue ZhangDepartment of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, Osaka University, Suita, Japan.
Xu ChengTaizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.
Kenan CenThe Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
Ying DaiThe Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
Yifeng MaiThe Affiliated Hospital of Medical School of Ningbo University, Ningbo, China.
Kai HongDepartment of Thyroid and Breast Surgery, Ningbo First Hospital, Ningbo, China.
Ningbo No. 2 Hospital · CNNingbo University Affiliated Hospital · CNSir Run Run Shaw Hospital · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is one of the most common tumor types and has poor outcomes. In this study, a ubiquitination-related prognostic signature was constructed, and its association with immunotherapy response in BC was explored. A list of ubiquitination-related genes was obtained from the molecular signatures database, and a ubiquitination-related gene signature was obtained by least absolute shrinkage and selection operator Cox regression. The genes,

Indexed as

breast cancerimmunotherapyLASSOsignaturetumor microenvironmentubiquitination

Identifiers

PMID36685928
PMCPMC9845272
OpenAlexW4313586014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.